Mapvilinc Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 17 years ago on Wednesday, June 7, 2006, according to the United State Patent & Trademark Office
Word Mark Mapvilinc
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 78416730
Status Date Wednesday, June 7, 2006
Filing Date Wednesday, June 7, 2006
Attorney Nadine P. Flynn

Correspondent

Nadine P. Flynn
212 546-3661
Trademark Department
345 Park Avenue
New York, NY 10154

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, May 18, 2004
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.